The first Americans could begin to receive the vaccine of the covid-19 at the earliest next December 12, predicted this Sunday the main adviser of Operation “Warp Speed”, the White House team that tries to accelerate medical solutions to the pandemic.
Advisers from the US Food and Drug Administration (FDA) will meet on December 10 to decide whether to approve the vaccine developed by the pharmaceutical company Pfizer and its German partner BioNTech, which this Friday requested an emergency authorization for its preparation in the North American country.
If they give it the go-ahead that same day, the US government is “prepared to begin distributing the vaccines within 24 hours of their approval,” said the adviser to Operation “Warp Speed”, Moncef Slaoui, in an interview with the ABC News network.
“We will have the (first) vaccines (distributed) one day after approval, and we hope that people can begin to be immunized, I would say within 48 hours of approval, “that is, on December 12, Slaoui added.
If that happens, the expert calculated that the United States could return to the closest thing to a new normal “sometime in May” in 2021, when he estimated that 70% of the population will have received the vaccine and a group immunity.
The first vaccines will be distributed proportionally to the population of each state, and those territories will be able to decide who will have priority to receive it, usually among the high-risk population and medical professionals, Slaoui explained.
The government of Trump of people from the United States, and has not shared his plans with the team of President-elect Joe Biden, who has warned that such lack of cooperation could cost lives in the country.
The timetable outlined by Slaoui means that the first vaccines could begin to be administered more than a month before Biden takes office on January 20.
The vaccination effort must also address the mistrust of many Americans toward the vaccine: Only 58% of citizens are willing to have it administered, according to a poll published this week by Gallup.
Pfizer’s vaccine requires two doses given about three weeks apart, and has shown up to 95% efficacy in preliminary clinical trials, without major safety concerns.
The United States has another candidate that has also demonstrated the effectiveness of its vaccine, that of the pharmaceutical company Moderna, which could request emergency authorization shortly and that, unlike Pfizer, does owe it to the injection of funds from the United States Government. part of its success in the historically rapid development process of the preparation.
The North American country is in the midst of a rebound in covid-19 infections: it has already exceeded 12 million cases of coronavirus and already adds more than 255,000 deaths, more than any other country in the world.
Digsmak is a news publisher with over 12 years of reporting experiance; and have published in many industry leading publications and news sites.